Lapatinib induces downregulation of matrix metallopeptidase 1 and deactivation of ERK1/2 and PI3K pathway in endometrial cancer

被引：1
|
作者：
Lai, C. [1 ,2 ]
Lin, C. [1 ]
Chao, A. [1 ,2 ]
Hsueh, S. [1 ]
Wang, T. [1 ,2 ]
机构：
[1] Chang Gung Mem Hosp, Tao Yuan, Taiwan
[2] Chang Gung Univ, Tao Yuan, Taiwan
来源：
GYNECOLOGIC ONCOLOGY | 2012年 / 125卷
关键词：
D O I：
10.1016/j.ygyno.2011.12.336
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
335
引用
收藏
页码：S137 / S138
页数：2
相关论文
共 50 条
  • [21] The EphB2 tumor suppressor induces autophagic cell death via concomitant activation of the ERK1/2 and PI3K pathways
    Kandouz, Mustapha
    Haidara, Khadidja
    Zhao, Jing
    Brisson, Marie-Laure
    Batist, Gerald
    CELL CYCLE, 2010, 9 (02) : 398 - 407
  • [22] Autoinhibition of IL-15 expression in KC cells is ERK1/2 and PI3K dependent
    Zhang, S. -Q.
    Luo, X.
    Yang, S.
    Liu, J. -L.
    Yang, C. -J.
    Yin, X. -Y.
    Huang, H. -L.
    Zhang, X. -J.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2008, 68 (04) : 397 - 404
  • [23] PRMT5 is positively correlated with and interacts with the ERK1/2 & PI3K Pathways in CRC
    Shifteh, David
    Sapir, Tzuriel
    Pahmer, Moshe
    Goel, Sanjay
    Maitra, Radhashree
    CANCER RESEARCH, 2022, 82 (12)
  • [24] PI3K is required for insulin-stimulated but not EGF-stimulated ERK1/2 activation
    Liu, Lunhua
    Xie, Yili
    Lou, Liguang
    EUROPEAN JOURNAL OF CELL BIOLOGY, 2006, 85 (05) : 367 - 374
  • [25] E2 - BSA activates caveolin-1 via PI3K/ERK1/2 and lysosomal degradation pathway and contributes to EPC proliferation
    Tan, Zhi
    Zhou, Li-Jun
    Li, Yu
    Cui, Yu-Hong
    Xiang, Qiu-Ling
    Lin, Gui-Ping
    Wang, Ting-Huai
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 158 (01) : 46 - 53
  • [26] Angiogenin promotes tumoral growth and angiogenesis by regulating matrix metallopeptidase-2 expression via the ERK1/2 pathway
    M Miyake
    S Goodison
    A Lawton
    E Gomes-Giacoia
    C J Rosser
    Oncogene, 2015, 34 : 890 - 901
  • [27] Downregulation of HER2 by RIG1 involves the PI3K/Akt pathway in ovarian cancer cells
    Ou, Chien-Chih
    Hsu, Shih-Chung
    Hsieh, Yin-Hui
    Tsou, Wan-Ling
    Chuang, Tzu-Chao
    Liu, Jah-Yao
    Kao, Ming-Ching
    CARCINOGENESIS, 2008, 29 (02) : 299 - 306
  • [28] Activation of PI3K/Akt/mTOR Pathway and Dual Inhibitors of PI3K and mTOR in Endometrial Cancer
    Chen, Jiezhong
    Zhao, Kong-Nan
    Li, Rui
    Shao, Renfu
    Chen, Chen
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (26) : 3070 - 3080
  • [29] CrkL regulates SDF-1-induced breast cancer biology through balancing Erk1/2 and PI3K/Akt pathways
    Xin Lian
    Yu Jiao
    Yu Yang
    Zhipeng Wang
    Qijia Xuan
    Hang Liu
    Shan Lu
    Zunxian Wang
    Yue Liu
    Shuo Li
    Yuguang Yang
    Li Guo
    Ling Zhao
    Qingyuan Zhang
    Medical Oncology, 2015, 32
  • [30] CrkL regulates SDF-1-induced breast cancer biology through balancing Erk1/2 and PI3K/Akt pathways
    Lian, Xin
    Jiao, Yu
    Yang, Yu
    Wang, Zhipeng
    Xuan, Qijia
    Liu, Hang
    Lu, Shan
    Wang, Zunxian
    Liu, Yue
    Li, Shuo
    Yang, Yuguang
    Guo, Li
    Zhao, Ling
    Zhang, Qingyuan
    MEDICAL ONCOLOGY, 2015, 32 (01) : 1 - 8
12345